Ecosystem leverage Discover Echo's acquisition by CELLINK positions it within a larger life-science ecosystem, offering cross-sell and channel opportunities to CELLINK’s installed base. Sales teams should target institutions already purchasing from CELLINK and propose hybrid microscope upgrades or bundles that integrate with existing CELLINK instruments, capturing share from customers seeking single-vendor imaging solutions.

Unique product advantage The world’s first hybrid upright/inverted microscope with multiple imaging modes (brightfield, fluorescence, live cell, confocal) is a strong differentiator for labs consolidating instruments. Position as a cost- and space-saving ROI play—present TCO comparisons and configurable build options to procurement teams at universities, pharma labs, and CROs.

Fast procurement Transparent pricing and a build-your-own-system tool plus available in-person or virtual demos lower barriers to purchase. Use demo-driven campaigns and ROI calculators to accelerate closes with research departments planning platform refreshes or new facility builds.

Global growth potential With mid-market scale (employees 51-200, revenue in the tens of millions) the company has room to expand beyond San Diego. Focus on international labs, contract research organizations, and academic centers, leveraging CELLINK’s distribution network and online marketing to reach global buyers.

Channel partnerships Develop a formal channel program including distributors, systems integrators, and academic partners; provide enablement resources, case studies, and maintenance SLAs to drive repeat business and large-scale deployments. Given growth and capital backing, position Discover Echo as a scalable upgrade path within biotech imaging portfolios.